binx FDA-cleared platform already impacting human health—poised to transform care for millions BOSTON, Sept. 23, 2019 /PRNewswire/ -- binx health, the pioneer in anywhere, anytime testing for women's health, today announced the first real-world use of the binx io platform, delivering same-visit diagnosis and treatment for chlamydia (CT) a

TAMPA, Fla., Sept. 23, 2019 /PRNewswire/ -- Studies show "social determinants of health" – the conditions in which people live, learn, work and play – affect a wide range of health risks and outcomes. New data released today by WellCare Health Plans, Inc. (NYSE: WCG) ("WellCare") adds to the growing body of research by examining the social service needs in hi

PALO ALTO, Calif., Sept. 23, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced the United States Trade Representative (USTR) has granted exclusion of components sourced from China for linear accelerators manufactured in the U.S from Section 301 tariffs. The exemption became effective on September 20, 2019."We are

World-renowned faculty will present current evidence and potential clinical applications of CTCs for advanced breast and prostate cancer BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Sept. 23, 2019 /PRNewswire/ -- Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, will host a symposium o

ALBANY, N.Y., Sept. 23, 2019 /PRNewswire/ -- Healthy Alliance Independent Practice Association (IPA), Innovative Health Alliance of New York, LLC (IHANY), and Fidelis Care are partnering to provide critical funding and careful coordination of services to Medicaid members insured by

SAN DIEGO, and VANCOUVER, British Columbia, Sept. 23, 2019 /PRNewswire/ -- Phoenix Molecular Designs (PhoenixMD), a clinical stage biotechnology company developing precise cancer t

HUNT VALLEY, Md., Sept. 23, 2019 /PRNewswire/ -- Pharmaceutics International, Inc. (Pii), a Contract Development and Manufacturing Organization (CDMO) headquartered in Hunt Valley, Maryland, is pleased to announce the  commercial supply of Fulvestrant Injection 250mg/5ml drug product, which was recently approved by the FDA.  Pii

NEW YORK, Sept. 23, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium") today announced that a poster highlighting Iomab-B, its pivotal Phase 3 targeted conditioning candidate, was awarded Honorable Distinction at the 2019 SOHO (Society of Hematologic Oncology) Annual Meeting. SOHO is the only international society specific

BOSTON, Sept. 23, 2019 /PRNewswire/ -- Six in 10 Americans rate oral health as either "fair," "poor," or "very poor," according to independent research commissioned by DentaQuest and conducted by KRC Research. Further, more than half of patients (51%) are concerned about their oral health, making it the top health concern over heart, eye, digestive, mental, and skin heal

LAVAL, QC and SEATTLE, Sept. 23, 2019 /PRNewswire/ - Today, our merged affiliates, NEOMED-LABS, Pacific Biomarkers and PAIRimmune, are proud to announce the launch of our new international name, Nexelis, along with our unified vision and capabilities.